Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sinzinger

Showing results (211-220 of 672) with videos related to

Pageof 68
Sort By:
The Journal of International Medical Research|January 1, 1988
Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamoleH Sinzinger, J O'Grady, P Fitscha
European Journal of Nuclear Medicine|September 2, 1998
Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringesR Bartosch, S Granegger, H Sinzinger
Zentralblatt Fur Veterinarmedizin. Reihe C: Anatomie, Histologie, Embryologie|September 1, 1973
[Circulus arteriosus of the rat, mouse and golden hamster]W Firbas, H Sinzinger, M Schlemmer
Zeitschrift Fur Anatomie Und Entwicklungsgeschichte|January 1, 1972
[Length and number of precapillary anastomoses in human liver]W Feigl, H Sinzinger, L Reisinger
British Journal of Experimental Pathology|February 1, 1979
Prostacyclin activity in rat kidney stimulated by angiotensin IIK Silberbauer, H Sinzinger, M Winter
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
European Journal of Nuclear Medicine|January 1, 1988
Insufficient binding of monoclonal antibody Mabgc to granulocytes in vivo and in vitroV Weiler, C Müller, H Sinzinger
Blood Vessels|January 1, 1980
Does prostacyclin (PGI2) regulate human arterial intima smooth muscle cell proliferation in early atherogenesis?H Sinzinger, K Silberbauer, W Auerswald
Thrombosis and Haemostasis|July 15, 1980
Prostacyclin formation by rat endothelial layerH Sinzinger, K Silberbauer, W Auerswald
Prostaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J Kaliman
Pageof 68

Showing results (211-220 of 672) with videos related to

Sort By:
Pageof 68
The Journal of International Medical Research|January 1, 1988
Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamoleH Sinzinger, J O'Grady, P Fitscha
European Journal of Nuclear Medicine|September 2, 1998
Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringesR Bartosch, S Granegger, H Sinzinger
Zentralblatt Fur Veterinarmedizin. Reihe C: Anatomie, Histologie, Embryologie|September 1, 1973
[Circulus arteriosus of the rat, mouse and golden hamster]W Firbas, H Sinzinger, M Schlemmer
Zeitschrift Fur Anatomie Und Entwicklungsgeschichte|January 1, 1972
[Length and number of precapillary anastomoses in human liver]W Feigl, H Sinzinger, L Reisinger
British Journal of Experimental Pathology|February 1, 1979
Prostacyclin activity in rat kidney stimulated by angiotensin IIK Silberbauer, H Sinzinger, M Winter
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
European Journal of Nuclear Medicine|January 1, 1988
Insufficient binding of monoclonal antibody Mabgc to granulocytes in vivo and in vitroV Weiler, C Müller, H Sinzinger
Blood Vessels|January 1, 1980
Does prostacyclin (PGI2) regulate human arterial intima smooth muscle cell proliferation in early atherogenesis?H Sinzinger, K Silberbauer, W Auerswald
Thrombosis and Haemostasis|July 15, 1980
Prostacyclin formation by rat endothelial layerH Sinzinger, K Silberbauer, W Auerswald
Prostaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J Kaliman
Pageof 68